IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity

Differentiating secondary from primary dengue using IgG to IgM ratio in early dengue: an observational hospital based clinico-serological study from North India

(2016) Khalid Hamid Changal et al.   BMC INFECTIOUS DISEASES

Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus

(2016) Lalita Priyamvada et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Antibody-Dependent Enhancement of Dengue Virus Infection in Primary Human Macrophages; Balancing Higher Fusion against Antiviral Responses

(2016) Jacky Flipse et al.   Scientific Reports

Association of FcγRIIa Polymorphism with Clinical Outcome of Dengue Infection: First Insight from Pakistan

(2015) Saima Naz Mohsin et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Immunoglobulin G (IgG) to IgM ratio in secondary adult dengue infection using samples from early days of symptoms onset

(2015) Cucunawangsih et al.   BMC INFECTIOUS DISEASES

Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy

(2015) Taia T. Wang et al.   CELL

Dengue Virus Infection Induces Expansion of a CD14+CD16+ Monocyte Population that Stimulates Plasmablast Differentiation

(2014) Marcin Kwissa et al.   Cell Host & Microbe

Validation of the Wild-type Influenza A Human Challenge Model H1N1pdMIST: An A(H1N1)pdm09 Dose-Finding Investigational New Drug Study

(2014) Matthew J. Memoli et al.   CLINICAL INFECTIOUS DISEASES

Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection

(2013) Maria G. Guzman et al.   ARCHIVES OF VIROLOGY

Preclinical Activity of the Type II CD20 Antibody GA101 (Obinutuzumab) Compared with Rituximab and Ofatumumab In Vitro and in Xenograft Models

(2013) S. Herter et al.   MOLECULAR CANCER THERAPEUTICS

Dengue Virus Co-opts UBR4 to Degrade STAT2 and Antagonize Type I Interferon Signaling

(2013) Juliet Morrison et al.   PLoS Pathogens

Novel roles for the IgG Fc glycan

(2012) Robert M. Anthony et al.   Annals of the New York Academy of Sciences

Mouse model recapitulating human Fc  receptor structural and functional diversity

(2012) P. Smith et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Comparative characterization of the glycosylation profiles of an influenza hemagglutinin produced in plant and insect hosts

(2012) Sheng Zhang et al.   PROTEOMICS

Molecular Mechanisms Involved in Antibody-Dependent Enhancement of Dengue Virus Infection in Humans

(2012) Jacky Flipse et al.   TRAFFIC

Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway

(2011) Robert M. Anthony et al.   NATURE

Dynamics of Dengue Disease Severity Determined by the Interplay Between Viral Genetics and Serotype-Specific Immunity

(2011) M. OhAinle et al.   Science Translational Medicine

Asymptomatic Dengue Infection in a Cuban Population Confirms the Protective Role of the RR Variant of the FcγRIIa Polymorphism

(2010) Gissel García et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Variant in CD209 promoter is associated with severity of liver disease in chronic hepatitis C virus infection

(2010) Elizabeth J. Ryan et al.   HUMAN IMMUNOLOGY

Mechanisms of Immune Evasion Induced by a Complex of Dengue Virus and Preexisting Enhancing Antibodies

(2010) Sukathida Ubol et al.   JOURNAL OF INFECTIOUS DISEASES

Human antibodies against dengue enhance dengue viral infectivity without suppressing type I interferon secretion in primary human monocytes

(2010) Zhihua Kou et al.   VIROLOGY

Subversion of Innate Defenses by the Interplay between DENV and Pre-Existing Enhancing Antibodies: TLRs Signaling Collapse

(2010) Naphak Modhiran et al.   PLoS Neglected Tropical Diseases

Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc

(2008) R. M. Anthony et al.   SCIENCE